Global Prenatal Second-Generation DNA Sequencing Supply, Demand and Key Producers, 2026-2032
The global Prenatal Second-Generation DNA Sequencing market size is expected to reach $ 1869 million by 2032, rising at a market growth of 10.7% CAGR during the forecast period (2026-2032).
Prenatal Second-Generation DNA Sequencing refers to prenatal genetic testing that uses second-generation next-generation sequencing methods to generate DNA sequence information relevant to a pregnancy for screening or diagnostic assessment. It typically relies on high-throughput short-read sequencing and computational analysis to detect fetal genetic signals, interpret genomic variation, and produce clinically actionable results that guide follow-up testing and pregnancy management. The approach can be applied through noninvasive workflows that analyze fetal genetic material present in maternal blood as well as through sequencing of fetal or placental samples obtained via clinical procedures, with outputs delivered as structured reports designed to support medical decision making and genetic counseling.
Prenatal Second-Generation DNA Sequencing is becoming a central engine of modernization in prenatal care as health systems seek earlier, safer, and more information-rich assessment of fetal genetic risk. From a research report perspective, market momentum is driven by the scalability of high-throughput sequencing workflows, improving bioinformatics and laboratory automation, and a steady expansion of clinical use cases from core aneuploidy screening toward broader panels and, in selected high-risk pathways, more comprehensive sequencing-based diagnostics. Competitive dynamics are increasingly shaped by analytical performance in low fetal signal conditions, robustness of variant calling and classification, turnaround reliability, integration with clinician-friendly reporting and counseling pathways, and the ability to operate within tightening regulatory and reimbursement expectations. As adoption deepens, differentiation will continue to shift from basic sequencing capacity to end-to-end clinical governance and operational execution, favoring providers that can deliver consistent quality, strong interpretability, and scalable service networks across geographies.
This report studies the global Prenatal Second-Generation DNA Sequencing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Prenatal Second-Generation DNA Sequencing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Prenatal Second-Generation DNA Sequencing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Prenatal Second-Generation DNA Sequencing total market, 2021-2032, (USD Million)
Global Prenatal Second-Generation DNA Sequencing total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Prenatal Second-Generation DNA Sequencing total market, key domestic companies, and share, (USD Million)
Global Prenatal Second-Generation DNA Sequencing revenue by player, revenue and market share 2021-2026, (USD Million)
Global Prenatal Second-Generation DNA Sequencing total market by Type, CAGR, 2021-2032, (USD Million)
Global Prenatal Second-Generation DNA Sequencing total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Prenatal Second-Generation DNA Sequencing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Natera, Labcorp, Quest Diagnostics, MedGenome, Mayo Clinic Laboratories, GeneDx, PreventionGenetics, SYNLAB, Myriad Genetics, GGA, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Prenatal Second-Generation DNA Sequencing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Prenatal Second-Generation DNA Sequencing Market, By Region:
1. How big is the global Prenatal Second-Generation DNA Sequencing market?
2. What is the demand of the global Prenatal Second-Generation DNA Sequencing market?
3. What is the year over year growth of the global Prenatal Second-Generation DNA Sequencing market?
4. What is the total value of the global Prenatal Second-Generation DNA Sequencing market?
5. Who are the Major Players in the global Prenatal Second-Generation DNA Sequencing market?
6. What are the growth factors driving the market demand?
Prenatal Second-Generation DNA Sequencing refers to prenatal genetic testing that uses second-generation next-generation sequencing methods to generate DNA sequence information relevant to a pregnancy for screening or diagnostic assessment. It typically relies on high-throughput short-read sequencing and computational analysis to detect fetal genetic signals, interpret genomic variation, and produce clinically actionable results that guide follow-up testing and pregnancy management. The approach can be applied through noninvasive workflows that analyze fetal genetic material present in maternal blood as well as through sequencing of fetal or placental samples obtained via clinical procedures, with outputs delivered as structured reports designed to support medical decision making and genetic counseling.
Prenatal Second-Generation DNA Sequencing is becoming a central engine of modernization in prenatal care as health systems seek earlier, safer, and more information-rich assessment of fetal genetic risk. From a research report perspective, market momentum is driven by the scalability of high-throughput sequencing workflows, improving bioinformatics and laboratory automation, and a steady expansion of clinical use cases from core aneuploidy screening toward broader panels and, in selected high-risk pathways, more comprehensive sequencing-based diagnostics. Competitive dynamics are increasingly shaped by analytical performance in low fetal signal conditions, robustness of variant calling and classification, turnaround reliability, integration with clinician-friendly reporting and counseling pathways, and the ability to operate within tightening regulatory and reimbursement expectations. As adoption deepens, differentiation will continue to shift from basic sequencing capacity to end-to-end clinical governance and operational execution, favoring providers that can deliver consistent quality, strong interpretability, and scalable service networks across geographies.
This report studies the global Prenatal Second-Generation DNA Sequencing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Prenatal Second-Generation DNA Sequencing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Prenatal Second-Generation DNA Sequencing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Prenatal Second-Generation DNA Sequencing total market, 2021-2032, (USD Million)
Global Prenatal Second-Generation DNA Sequencing total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Prenatal Second-Generation DNA Sequencing total market, key domestic companies, and share, (USD Million)
Global Prenatal Second-Generation DNA Sequencing revenue by player, revenue and market share 2021-2026, (USD Million)
Global Prenatal Second-Generation DNA Sequencing total market by Type, CAGR, 2021-2032, (USD Million)
Global Prenatal Second-Generation DNA Sequencing total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Prenatal Second-Generation DNA Sequencing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Natera, Labcorp, Quest Diagnostics, MedGenome, Mayo Clinic Laboratories, GeneDx, PreventionGenetics, SYNLAB, Myriad Genetics, GGA, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Prenatal Second-Generation DNA Sequencing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Prenatal Second-Generation DNA Sequencing Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Targeted Panels
- Exome Sequencing
- Others
- Non-Invasive
- Invasive
- Public Health Program
- Consumer
- Others
- Public Hospitals
- Private Hospitals
- Natera
- Labcorp
- Quest Diagnostics
- MedGenome
- Mayo Clinic Laboratories
- GeneDx
- PreventionGenetics
- SYNLAB
- Myriad Genetics
- GGA
- Fulgent Genetics
- Rainbow Genomics
- BillionToOne
- BGI Genomics
- Berry Genomics
- Annaroad
- Weihansi Biomedical Technology
1. How big is the global Prenatal Second-Generation DNA Sequencing market?
2. What is the demand of the global Prenatal Second-Generation DNA Sequencing market?
3. What is the year over year growth of the global Prenatal Second-Generation DNA Sequencing market?
4. What is the total value of the global Prenatal Second-Generation DNA Sequencing market?
5. Who are the Major Players in the global Prenatal Second-Generation DNA Sequencing market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Prenatal Second-Generation DNA Sequencing Introduction
1.2 World Prenatal Second-Generation DNA Sequencing Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Prenatal Second-Generation DNA Sequencing Total Market by Region (by Headquarter Location)
1.3.1 World Prenatal Second-Generation DNA Sequencing Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Prenatal Second-Generation DNA Sequencing Revenue (2021-2032)
1.3.3 China Based Company Prenatal Second-Generation DNA Sequencing Revenue (2021-2032)
1.3.4 Europe Based Company Prenatal Second-Generation DNA Sequencing Revenue (2021-2032)
1.3.5 Japan Based Company Prenatal Second-Generation DNA Sequencing Revenue (2021-2032)
1.3.6 South Korea Based Company Prenatal Second-Generation DNA Sequencing Revenue (2021-2032)
1.3.7 ASEAN Based Company Prenatal Second-Generation DNA Sequencing Revenue (2021-2032)
1.3.8 India Based Company Prenatal Second-Generation DNA Sequencing Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Prenatal Second-Generation DNA Sequencing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Prenatal Second-Generation DNA Sequencing Consumption Value (2021-2032)
2.2 World Prenatal Second-Generation DNA Sequencing Consumption Value by Region
2.2.1 World Prenatal Second-Generation DNA Sequencing Consumption Value by Region (2021-2026)
2.2.2 World Prenatal Second-Generation DNA Sequencing Consumption Value Forecast by Region (2027-2032)
2.3 United States Prenatal Second-Generation DNA Sequencing Consumption Value (2021-2032)
2.4 China Prenatal Second-Generation DNA Sequencing Consumption Value (2021-2032)
2.5 Europe Prenatal Second-Generation DNA Sequencing Consumption Value (2021-2032)
2.6 Japan Prenatal Second-Generation DNA Sequencing Consumption Value (2021-2032)
2.7 South Korea Prenatal Second-Generation DNA Sequencing Consumption Value (2021-2032)
2.8 ASEAN Prenatal Second-Generation DNA Sequencing Consumption Value (2021-2032)
2.9 India Prenatal Second-Generation DNA Sequencing Consumption Value (2021-2032)
3 WORLD PRENATAL SECOND-GENERATION DNA SEQUENCING COMPANIES COMPETITIVE ANALYSIS
3.1 World Prenatal Second-Generation DNA Sequencing Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Prenatal Second-Generation DNA Sequencing Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Prenatal Second-Generation DNA Sequencing in 2025
3.2.3 Global Concentration Ratios (CR8) for Prenatal Second-Generation DNA Sequencing in 2025
3.3 Prenatal Second-Generation DNA Sequencing Company Evaluation Quadrant
3.4 Prenatal Second-Generation DNA Sequencing Market: Overall Company Footprint Analysis
3.4.1 Prenatal Second-Generation DNA Sequencing Market: Region Footprint
3.4.2 Prenatal Second-Generation DNA Sequencing Market: Company Product Type Footprint
3.4.3 Prenatal Second-Generation DNA Sequencing Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Prenatal Second-Generation DNA Sequencing Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Prenatal Second-Generation DNA Sequencing Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Prenatal Second-Generation DNA Sequencing Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Prenatal Second-Generation DNA Sequencing Consumption Value Comparison
4.2.1 United States VS China: Prenatal Second-Generation DNA Sequencing Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Prenatal Second-Generation DNA Sequencing Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Prenatal Second-Generation DNA Sequencing Companies and Market Share, 2021-2026
4.3.1 United States Based Prenatal Second-Generation DNA Sequencing Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Prenatal Second-Generation DNA Sequencing Revenue, (2021-2026)
4.4 China Based Companies Prenatal Second-Generation DNA Sequencing Revenue and Market Share, 2021-2026
4.4.1 China Based Prenatal Second-Generation DNA Sequencing Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Prenatal Second-Generation DNA Sequencing Revenue, (2021-2026)
4.5 Rest of World Based Prenatal Second-Generation DNA Sequencing Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Prenatal Second-Generation DNA Sequencing Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Prenatal Second-Generation DNA Sequencing Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Prenatal Second-Generation DNA Sequencing Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Targeted Panels
5.2.2 Exome Sequencing
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Prenatal Second-Generation DNA Sequencing Market Size by Type (2021-2026)
5.3.2 World Prenatal Second-Generation DNA Sequencing Market Size by Type (2027-2032)
5.3.3 World Prenatal Second-Generation DNA Sequencing Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY INVASIVENESS
6.1 World Prenatal Second-Generation DNA Sequencing Market Size Overview by Invasiveness: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Invasiveness
6.2.1 Non-Invasive
6.2.2 Invasive
6.3 Market Segment by Invasiveness
6.3.1 World Prenatal Second-Generation DNA Sequencing Market Size by Invasiveness (2021-2026)
6.3.2 World Prenatal Second-Generation DNA Sequencing Market Size by Invasiveness (2027-2032)
6.3.3 World Prenatal Second-Generation DNA Sequencing Market Size Market Share by Invasiveness (2027-2032)
7 MARKET ANALYSIS BY SERVICE MODEL
7.1 World Prenatal Second-Generation DNA Sequencing Market Size Overview by Service Model: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Service Model
7.2.1 Public Health Program
7.2.2 Consumer
7.2.3 Others
7.3 Market Segment by Service Model
7.3.1 World Prenatal Second-Generation DNA Sequencing Market Size by Service Model (2021-2026)
7.3.2 World Prenatal Second-Generation DNA Sequencing Market Size by Service Model (2027-2032)
7.3.3 World Prenatal Second-Generation DNA Sequencing Market Size Market Share by Service Model (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Prenatal Second-Generation DNA Sequencing Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Public Hospitals
8.2.2 Private Hospitals
8.3 Market Segment by Application
8.3.1 World Prenatal Second-Generation DNA Sequencing Market Size by Application (2021-2026)
8.3.2 World Prenatal Second-Generation DNA Sequencing Market Size by Application (2027-2032)
8.3.3 World Prenatal Second-Generation DNA Sequencing Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Natera
9.1.1 Natera Details
9.1.2 Natera Major Business
9.1.3 Natera Prenatal Second-Generation DNA Sequencing Product and Services
9.1.4 Natera Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Natera Recent Developments/Updates
9.1.6 Natera Competitive Strengths & Weaknesses
9.2 Labcorp
9.2.1 Labcorp Details
9.2.2 Labcorp Major Business
9.2.3 Labcorp Prenatal Second-Generation DNA Sequencing Product and Services
9.2.4 Labcorp Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Labcorp Recent Developments/Updates
9.2.6 Labcorp Competitive Strengths & Weaknesses
9.3 Quest Diagnostics
9.3.1 Quest Diagnostics Details
9.3.2 Quest Diagnostics Major Business
9.3.3 Quest Diagnostics Prenatal Second-Generation DNA Sequencing Product and Services
9.3.4 Quest Diagnostics Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Quest Diagnostics Recent Developments/Updates
9.3.6 Quest Diagnostics Competitive Strengths & Weaknesses
9.4 MedGenome
9.4.1 MedGenome Details
9.4.2 MedGenome Major Business
9.4.3 MedGenome Prenatal Second-Generation DNA Sequencing Product and Services
9.4.4 MedGenome Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 MedGenome Recent Developments/Updates
9.4.6 MedGenome Competitive Strengths & Weaknesses
9.5 Mayo Clinic Laboratories
9.5.1 Mayo Clinic Laboratories Details
9.5.2 Mayo Clinic Laboratories Major Business
9.5.3 Mayo Clinic Laboratories Prenatal Second-Generation DNA Sequencing Product and Services
9.5.4 Mayo Clinic Laboratories Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Mayo Clinic Laboratories Recent Developments/Updates
9.5.6 Mayo Clinic Laboratories Competitive Strengths & Weaknesses
9.6 GeneDx
9.6.1 GeneDx Details
9.6.2 GeneDx Major Business
9.6.3 GeneDx Prenatal Second-Generation DNA Sequencing Product and Services
9.6.4 GeneDx Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 GeneDx Recent Developments/Updates
9.6.6 GeneDx Competitive Strengths & Weaknesses
9.7 PreventionGenetics
9.7.1 PreventionGenetics Details
9.7.2 PreventionGenetics Major Business
9.7.3 PreventionGenetics Prenatal Second-Generation DNA Sequencing Product and Services
9.7.4 PreventionGenetics Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 PreventionGenetics Recent Developments/Updates
9.7.6 PreventionGenetics Competitive Strengths & Weaknesses
9.8 SYNLAB
9.8.1 SYNLAB Details
9.8.2 SYNLAB Major Business
9.8.3 SYNLAB Prenatal Second-Generation DNA Sequencing Product and Services
9.8.4 SYNLAB Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 SYNLAB Recent Developments/Updates
9.8.6 SYNLAB Competitive Strengths & Weaknesses
9.9 Myriad Genetics
9.9.1 Myriad Genetics Details
9.9.2 Myriad Genetics Major Business
9.9.3 Myriad Genetics Prenatal Second-Generation DNA Sequencing Product and Services
9.9.4 Myriad Genetics Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Myriad Genetics Recent Developments/Updates
9.9.6 Myriad Genetics Competitive Strengths & Weaknesses
9.10 GGA
9.10.1 GGA Details
9.10.2 GGA Major Business
9.10.3 GGA Prenatal Second-Generation DNA Sequencing Product and Services
9.10.4 GGA Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 GGA Recent Developments/Updates
9.10.6 GGA Competitive Strengths & Weaknesses
9.11 Fulgent Genetics
9.11.1 Fulgent Genetics Details
9.11.2 Fulgent Genetics Major Business
9.11.3 Fulgent Genetics Prenatal Second-Generation DNA Sequencing Product and Services
9.11.4 Fulgent Genetics Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Fulgent Genetics Recent Developments/Updates
9.11.6 Fulgent Genetics Competitive Strengths & Weaknesses
9.12 Rainbow Genomics
9.12.1 Rainbow Genomics Details
9.12.2 Rainbow Genomics Major Business
9.12.3 Rainbow Genomics Prenatal Second-Generation DNA Sequencing Product and Services
9.12.4 Rainbow Genomics Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Rainbow Genomics Recent Developments/Updates
9.12.6 Rainbow Genomics Competitive Strengths & Weaknesses
9.13 BillionToOne
9.13.1 BillionToOne Details
9.13.2 BillionToOne Major Business
9.13.3 BillionToOne Prenatal Second-Generation DNA Sequencing Product and Services
9.13.4 BillionToOne Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 BillionToOne Recent Developments/Updates
9.13.6 BillionToOne Competitive Strengths & Weaknesses
9.14 BGI Genomics
9.14.1 BGI Genomics Details
9.14.2 BGI Genomics Major Business
9.14.3 BGI Genomics Prenatal Second-Generation DNA Sequencing Product and Services
9.14.4 BGI Genomics Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 BGI Genomics Recent Developments/Updates
9.14.6 BGI Genomics Competitive Strengths & Weaknesses
9.15 Berry Genomics
9.15.1 Berry Genomics Details
9.15.2 Berry Genomics Major Business
9.15.3 Berry Genomics Prenatal Second-Generation DNA Sequencing Product and Services
9.15.4 Berry Genomics Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Berry Genomics Recent Developments/Updates
9.15.6 Berry Genomics Competitive Strengths & Weaknesses
9.16 Annaroad
9.16.1 Annaroad Details
9.16.2 Annaroad Major Business
9.16.3 Annaroad Prenatal Second-Generation DNA Sequencing Product and Services
9.16.4 Annaroad Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Annaroad Recent Developments/Updates
9.16.6 Annaroad Competitive Strengths & Weaknesses
9.17 Weihansi Biomedical Technology
9.17.1 Weihansi Biomedical Technology Details
9.17.2 Weihansi Biomedical Technology Major Business
9.17.3 Weihansi Biomedical Technology Prenatal Second-Generation DNA Sequencing Product and Services
9.17.4 Weihansi Biomedical Technology Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Weihansi Biomedical Technology Recent Developments/Updates
9.17.6 Weihansi Biomedical Technology Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Prenatal Second-Generation DNA Sequencing Industry Chain
10.2 Prenatal Second-Generation DNA Sequencing Upstream Analysis
10.3 Prenatal Second-Generation DNA Sequencing Midstream Analysis
10.4 Prenatal Second-Generation DNA Sequencing Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Prenatal Second-Generation DNA Sequencing Introduction
1.2 World Prenatal Second-Generation DNA Sequencing Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Prenatal Second-Generation DNA Sequencing Total Market by Region (by Headquarter Location)
1.3.1 World Prenatal Second-Generation DNA Sequencing Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Prenatal Second-Generation DNA Sequencing Revenue (2021-2032)
1.3.3 China Based Company Prenatal Second-Generation DNA Sequencing Revenue (2021-2032)
1.3.4 Europe Based Company Prenatal Second-Generation DNA Sequencing Revenue (2021-2032)
1.3.5 Japan Based Company Prenatal Second-Generation DNA Sequencing Revenue (2021-2032)
1.3.6 South Korea Based Company Prenatal Second-Generation DNA Sequencing Revenue (2021-2032)
1.3.7 ASEAN Based Company Prenatal Second-Generation DNA Sequencing Revenue (2021-2032)
1.3.8 India Based Company Prenatal Second-Generation DNA Sequencing Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Prenatal Second-Generation DNA Sequencing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Prenatal Second-Generation DNA Sequencing Consumption Value (2021-2032)
2.2 World Prenatal Second-Generation DNA Sequencing Consumption Value by Region
2.2.1 World Prenatal Second-Generation DNA Sequencing Consumption Value by Region (2021-2026)
2.2.2 World Prenatal Second-Generation DNA Sequencing Consumption Value Forecast by Region (2027-2032)
2.3 United States Prenatal Second-Generation DNA Sequencing Consumption Value (2021-2032)
2.4 China Prenatal Second-Generation DNA Sequencing Consumption Value (2021-2032)
2.5 Europe Prenatal Second-Generation DNA Sequencing Consumption Value (2021-2032)
2.6 Japan Prenatal Second-Generation DNA Sequencing Consumption Value (2021-2032)
2.7 South Korea Prenatal Second-Generation DNA Sequencing Consumption Value (2021-2032)
2.8 ASEAN Prenatal Second-Generation DNA Sequencing Consumption Value (2021-2032)
2.9 India Prenatal Second-Generation DNA Sequencing Consumption Value (2021-2032)
3 WORLD PRENATAL SECOND-GENERATION DNA SEQUENCING COMPANIES COMPETITIVE ANALYSIS
3.1 World Prenatal Second-Generation DNA Sequencing Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Prenatal Second-Generation DNA Sequencing Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Prenatal Second-Generation DNA Sequencing in 2025
3.2.3 Global Concentration Ratios (CR8) for Prenatal Second-Generation DNA Sequencing in 2025
3.3 Prenatal Second-Generation DNA Sequencing Company Evaluation Quadrant
3.4 Prenatal Second-Generation DNA Sequencing Market: Overall Company Footprint Analysis
3.4.1 Prenatal Second-Generation DNA Sequencing Market: Region Footprint
3.4.2 Prenatal Second-Generation DNA Sequencing Market: Company Product Type Footprint
3.4.3 Prenatal Second-Generation DNA Sequencing Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Prenatal Second-Generation DNA Sequencing Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Prenatal Second-Generation DNA Sequencing Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Prenatal Second-Generation DNA Sequencing Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Prenatal Second-Generation DNA Sequencing Consumption Value Comparison
4.2.1 United States VS China: Prenatal Second-Generation DNA Sequencing Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Prenatal Second-Generation DNA Sequencing Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Prenatal Second-Generation DNA Sequencing Companies and Market Share, 2021-2026
4.3.1 United States Based Prenatal Second-Generation DNA Sequencing Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Prenatal Second-Generation DNA Sequencing Revenue, (2021-2026)
4.4 China Based Companies Prenatal Second-Generation DNA Sequencing Revenue and Market Share, 2021-2026
4.4.1 China Based Prenatal Second-Generation DNA Sequencing Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Prenatal Second-Generation DNA Sequencing Revenue, (2021-2026)
4.5 Rest of World Based Prenatal Second-Generation DNA Sequencing Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Prenatal Second-Generation DNA Sequencing Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Prenatal Second-Generation DNA Sequencing Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Prenatal Second-Generation DNA Sequencing Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Targeted Panels
5.2.2 Exome Sequencing
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Prenatal Second-Generation DNA Sequencing Market Size by Type (2021-2026)
5.3.2 World Prenatal Second-Generation DNA Sequencing Market Size by Type (2027-2032)
5.3.3 World Prenatal Second-Generation DNA Sequencing Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY INVASIVENESS
6.1 World Prenatal Second-Generation DNA Sequencing Market Size Overview by Invasiveness: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Invasiveness
6.2.1 Non-Invasive
6.2.2 Invasive
6.3 Market Segment by Invasiveness
6.3.1 World Prenatal Second-Generation DNA Sequencing Market Size by Invasiveness (2021-2026)
6.3.2 World Prenatal Second-Generation DNA Sequencing Market Size by Invasiveness (2027-2032)
6.3.3 World Prenatal Second-Generation DNA Sequencing Market Size Market Share by Invasiveness (2027-2032)
7 MARKET ANALYSIS BY SERVICE MODEL
7.1 World Prenatal Second-Generation DNA Sequencing Market Size Overview by Service Model: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Service Model
7.2.1 Public Health Program
7.2.2 Consumer
7.2.3 Others
7.3 Market Segment by Service Model
7.3.1 World Prenatal Second-Generation DNA Sequencing Market Size by Service Model (2021-2026)
7.3.2 World Prenatal Second-Generation DNA Sequencing Market Size by Service Model (2027-2032)
7.3.3 World Prenatal Second-Generation DNA Sequencing Market Size Market Share by Service Model (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Prenatal Second-Generation DNA Sequencing Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Public Hospitals
8.2.2 Private Hospitals
8.3 Market Segment by Application
8.3.1 World Prenatal Second-Generation DNA Sequencing Market Size by Application (2021-2026)
8.3.2 World Prenatal Second-Generation DNA Sequencing Market Size by Application (2027-2032)
8.3.3 World Prenatal Second-Generation DNA Sequencing Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Natera
9.1.1 Natera Details
9.1.2 Natera Major Business
9.1.3 Natera Prenatal Second-Generation DNA Sequencing Product and Services
9.1.4 Natera Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Natera Recent Developments/Updates
9.1.6 Natera Competitive Strengths & Weaknesses
9.2 Labcorp
9.2.1 Labcorp Details
9.2.2 Labcorp Major Business
9.2.3 Labcorp Prenatal Second-Generation DNA Sequencing Product and Services
9.2.4 Labcorp Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Labcorp Recent Developments/Updates
9.2.6 Labcorp Competitive Strengths & Weaknesses
9.3 Quest Diagnostics
9.3.1 Quest Diagnostics Details
9.3.2 Quest Diagnostics Major Business
9.3.3 Quest Diagnostics Prenatal Second-Generation DNA Sequencing Product and Services
9.3.4 Quest Diagnostics Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Quest Diagnostics Recent Developments/Updates
9.3.6 Quest Diagnostics Competitive Strengths & Weaknesses
9.4 MedGenome
9.4.1 MedGenome Details
9.4.2 MedGenome Major Business
9.4.3 MedGenome Prenatal Second-Generation DNA Sequencing Product and Services
9.4.4 MedGenome Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 MedGenome Recent Developments/Updates
9.4.6 MedGenome Competitive Strengths & Weaknesses
9.5 Mayo Clinic Laboratories
9.5.1 Mayo Clinic Laboratories Details
9.5.2 Mayo Clinic Laboratories Major Business
9.5.3 Mayo Clinic Laboratories Prenatal Second-Generation DNA Sequencing Product and Services
9.5.4 Mayo Clinic Laboratories Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Mayo Clinic Laboratories Recent Developments/Updates
9.5.6 Mayo Clinic Laboratories Competitive Strengths & Weaknesses
9.6 GeneDx
9.6.1 GeneDx Details
9.6.2 GeneDx Major Business
9.6.3 GeneDx Prenatal Second-Generation DNA Sequencing Product and Services
9.6.4 GeneDx Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 GeneDx Recent Developments/Updates
9.6.6 GeneDx Competitive Strengths & Weaknesses
9.7 PreventionGenetics
9.7.1 PreventionGenetics Details
9.7.2 PreventionGenetics Major Business
9.7.3 PreventionGenetics Prenatal Second-Generation DNA Sequencing Product and Services
9.7.4 PreventionGenetics Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 PreventionGenetics Recent Developments/Updates
9.7.6 PreventionGenetics Competitive Strengths & Weaknesses
9.8 SYNLAB
9.8.1 SYNLAB Details
9.8.2 SYNLAB Major Business
9.8.3 SYNLAB Prenatal Second-Generation DNA Sequencing Product and Services
9.8.4 SYNLAB Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 SYNLAB Recent Developments/Updates
9.8.6 SYNLAB Competitive Strengths & Weaknesses
9.9 Myriad Genetics
9.9.1 Myriad Genetics Details
9.9.2 Myriad Genetics Major Business
9.9.3 Myriad Genetics Prenatal Second-Generation DNA Sequencing Product and Services
9.9.4 Myriad Genetics Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Myriad Genetics Recent Developments/Updates
9.9.6 Myriad Genetics Competitive Strengths & Weaknesses
9.10 GGA
9.10.1 GGA Details
9.10.2 GGA Major Business
9.10.3 GGA Prenatal Second-Generation DNA Sequencing Product and Services
9.10.4 GGA Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 GGA Recent Developments/Updates
9.10.6 GGA Competitive Strengths & Weaknesses
9.11 Fulgent Genetics
9.11.1 Fulgent Genetics Details
9.11.2 Fulgent Genetics Major Business
9.11.3 Fulgent Genetics Prenatal Second-Generation DNA Sequencing Product and Services
9.11.4 Fulgent Genetics Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Fulgent Genetics Recent Developments/Updates
9.11.6 Fulgent Genetics Competitive Strengths & Weaknesses
9.12 Rainbow Genomics
9.12.1 Rainbow Genomics Details
9.12.2 Rainbow Genomics Major Business
9.12.3 Rainbow Genomics Prenatal Second-Generation DNA Sequencing Product and Services
9.12.4 Rainbow Genomics Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Rainbow Genomics Recent Developments/Updates
9.12.6 Rainbow Genomics Competitive Strengths & Weaknesses
9.13 BillionToOne
9.13.1 BillionToOne Details
9.13.2 BillionToOne Major Business
9.13.3 BillionToOne Prenatal Second-Generation DNA Sequencing Product and Services
9.13.4 BillionToOne Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 BillionToOne Recent Developments/Updates
9.13.6 BillionToOne Competitive Strengths & Weaknesses
9.14 BGI Genomics
9.14.1 BGI Genomics Details
9.14.2 BGI Genomics Major Business
9.14.3 BGI Genomics Prenatal Second-Generation DNA Sequencing Product and Services
9.14.4 BGI Genomics Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 BGI Genomics Recent Developments/Updates
9.14.6 BGI Genomics Competitive Strengths & Weaknesses
9.15 Berry Genomics
9.15.1 Berry Genomics Details
9.15.2 Berry Genomics Major Business
9.15.3 Berry Genomics Prenatal Second-Generation DNA Sequencing Product and Services
9.15.4 Berry Genomics Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Berry Genomics Recent Developments/Updates
9.15.6 Berry Genomics Competitive Strengths & Weaknesses
9.16 Annaroad
9.16.1 Annaroad Details
9.16.2 Annaroad Major Business
9.16.3 Annaroad Prenatal Second-Generation DNA Sequencing Product and Services
9.16.4 Annaroad Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Annaroad Recent Developments/Updates
9.16.6 Annaroad Competitive Strengths & Weaknesses
9.17 Weihansi Biomedical Technology
9.17.1 Weihansi Biomedical Technology Details
9.17.2 Weihansi Biomedical Technology Major Business
9.17.3 Weihansi Biomedical Technology Prenatal Second-Generation DNA Sequencing Product and Services
9.17.4 Weihansi Biomedical Technology Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Weihansi Biomedical Technology Recent Developments/Updates
9.17.6 Weihansi Biomedical Technology Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Prenatal Second-Generation DNA Sequencing Industry Chain
10.2 Prenatal Second-Generation DNA Sequencing Upstream Analysis
10.3 Prenatal Second-Generation DNA Sequencing Midstream Analysis
10.4 Prenatal Second-Generation DNA Sequencing Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Prenatal Second-Generation DNA Sequencing Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Prenatal Second-Generation DNA Sequencing Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Prenatal Second-Generation DNA Sequencing Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Prenatal Second-Generation DNA Sequencing Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Prenatal Second-Generation DNA Sequencing Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Prenatal Second-Generation DNA Sequencing Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Prenatal Second-Generation DNA Sequencing Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Prenatal Second-Generation DNA Sequencing Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Prenatal Second-Generation DNA Sequencing Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Prenatal Second-Generation DNA Sequencing Players in 2025
Table 12. World Prenatal Second-Generation DNA Sequencing Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Prenatal Second-Generation DNA Sequencing Company Evaluation Quadrant
Table 14. Head Office of Key Prenatal Second-Generation DNA Sequencing Players
Table 15. Prenatal Second-Generation DNA Sequencing Market: Company Product Type Footprint
Table 16. Prenatal Second-Generation DNA Sequencing Market: Company Product Application Footprint
Table 17. Prenatal Second-Generation DNA Sequencing Mergers & Acquisitions Activity
Table 18. United States VS China Prenatal Second-Generation DNA Sequencing Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Prenatal Second-Generation DNA Sequencing Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Prenatal Second-Generation DNA Sequencing Companies, Headquarters (States, Country)
Table 21. United States Based Companies Prenatal Second-Generation DNA Sequencing Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Prenatal Second-Generation DNA Sequencing Revenue Market Share (2021-2026)
Table 23. China Based Prenatal Second-Generation DNA Sequencing Companies, Headquarters (Province, Country)
Table 24. China Based Companies Prenatal Second-Generation DNA Sequencing Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Prenatal Second-Generation DNA Sequencing Revenue Market Share (2021-2026)
Table 26. Rest of World Based Prenatal Second-Generation DNA Sequencing Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Prenatal Second-Generation DNA Sequencing Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Prenatal Second-Generation DNA Sequencing Revenue Market Share (2021-2026)
Table 29. World Prenatal Second-Generation DNA Sequencing Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Prenatal Second-Generation DNA Sequencing Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Prenatal Second-Generation DNA Sequencing Market Size by Type (2027-2032) & (USD Million)
Table 32. World Prenatal Second-Generation DNA Sequencing Market Size by Invasiveness, (USD Million), 2021 & 2025 & 2032
Table 33. World Prenatal Second-Generation DNA Sequencing Market Size Value by Invasiveness (2021-2026) & (USD Million)
Table 34. World Prenatal Second-Generation DNA Sequencing Market Size by Invasiveness (2027-2032) & (USD Million)
Table 35. World Prenatal Second-Generation DNA Sequencing Market Size by Service Model, (USD Million), 2021 & 2025 & 2032
Table 36. World Prenatal Second-Generation DNA Sequencing Market Size Value by Service Model (2021-2026) & (USD Million)
Table 37. World Prenatal Second-Generation DNA Sequencing Market Size by Service Model (2027-2032) & (USD Million)
Table 38. World Prenatal Second-Generation DNA Sequencing Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Prenatal Second-Generation DNA Sequencing Market Size by Application (2021-2026) & (USD Million)
Table 40. World Prenatal Second-Generation DNA Sequencing Market Size by Application (2027-2032) & (USD Million)
Table 41. Natera Basic Information, Manufacturing Base and Competitors
Table 42. Natera Major Business
Table 43. Natera Prenatal Second-Generation DNA Sequencing Product and Services
Table 44. Natera Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Natera Recent Developments/Updates
Table 46. Natera Competitive Strengths & Weaknesses
Table 47. Labcorp Basic Information, Manufacturing Base and Competitors
Table 48. Labcorp Major Business
Table 49. Labcorp Prenatal Second-Generation DNA Sequencing Product and Services
Table 50. Labcorp Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Labcorp Recent Developments/Updates
Table 52. Labcorp Competitive Strengths & Weaknesses
Table 53. Quest Diagnostics Basic Information, Manufacturing Base and Competitors
Table 54. Quest Diagnostics Major Business
Table 55. Quest Diagnostics Prenatal Second-Generation DNA Sequencing Product and Services
Table 56. Quest Diagnostics Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Quest Diagnostics Recent Developments/Updates
Table 58. Quest Diagnostics Competitive Strengths & Weaknesses
Table 59. MedGenome Basic Information, Manufacturing Base and Competitors
Table 60. MedGenome Major Business
Table 61. MedGenome Prenatal Second-Generation DNA Sequencing Product and Services
Table 62. MedGenome Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. MedGenome Recent Developments/Updates
Table 64. MedGenome Competitive Strengths & Weaknesses
Table 65. Mayo Clinic Laboratories Basic Information, Manufacturing Base and Competitors
Table 66. Mayo Clinic Laboratories Major Business
Table 67. Mayo Clinic Laboratories Prenatal Second-Generation DNA Sequencing Product and Services
Table 68. Mayo Clinic Laboratories Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Mayo Clinic Laboratories Recent Developments/Updates
Table 70. Mayo Clinic Laboratories Competitive Strengths & Weaknesses
Table 71. GeneDx Basic Information, Manufacturing Base and Competitors
Table 72. GeneDx Major Business
Table 73. GeneDx Prenatal Second-Generation DNA Sequencing Product and Services
Table 74. GeneDx Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. GeneDx Recent Developments/Updates
Table 76. GeneDx Competitive Strengths & Weaknesses
Table 77. PreventionGenetics Basic Information, Manufacturing Base and Competitors
Table 78. PreventionGenetics Major Business
Table 79. PreventionGenetics Prenatal Second-Generation DNA Sequencing Product and Services
Table 80. PreventionGenetics Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. PreventionGenetics Recent Developments/Updates
Table 82. PreventionGenetics Competitive Strengths & Weaknesses
Table 83. SYNLAB Basic Information, Manufacturing Base and Competitors
Table 84. SYNLAB Major Business
Table 85. SYNLAB Prenatal Second-Generation DNA Sequencing Product and Services
Table 86. SYNLAB Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. SYNLAB Recent Developments/Updates
Table 88. SYNLAB Competitive Strengths & Weaknesses
Table 89. Myriad Genetics Basic Information, Manufacturing Base and Competitors
Table 90. Myriad Genetics Major Business
Table 91. Myriad Genetics Prenatal Second-Generation DNA Sequencing Product and Services
Table 92. Myriad Genetics Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Myriad Genetics Recent Developments/Updates
Table 94. Myriad Genetics Competitive Strengths & Weaknesses
Table 95. GGA Basic Information, Manufacturing Base and Competitors
Table 96. GGA Major Business
Table 97. GGA Prenatal Second-Generation DNA Sequencing Product and Services
Table 98. GGA Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. GGA Recent Developments/Updates
Table 100. GGA Competitive Strengths & Weaknesses
Table 101. Fulgent Genetics Basic Information, Manufacturing Base and Competitors
Table 102. Fulgent Genetics Major Business
Table 103. Fulgent Genetics Prenatal Second-Generation DNA Sequencing Product and Services
Table 104. Fulgent Genetics Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Fulgent Genetics Recent Developments/Updates
Table 106. Fulgent Genetics Competitive Strengths & Weaknesses
Table 107. Rainbow Genomics Basic Information, Manufacturing Base and Competitors
Table 108. Rainbow Genomics Major Business
Table 109. Rainbow Genomics Prenatal Second-Generation DNA Sequencing Product and Services
Table 110. Rainbow Genomics Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Rainbow Genomics Recent Developments/Updates
Table 112. Rainbow Genomics Competitive Strengths & Weaknesses
Table 113. BillionToOne Basic Information, Manufacturing Base and Competitors
Table 114. BillionToOne Major Business
Table 115. BillionToOne Prenatal Second-Generation DNA Sequencing Product and Services
Table 116. BillionToOne Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. BillionToOne Recent Developments/Updates
Table 118. BillionToOne Competitive Strengths & Weaknesses
Table 119. BGI Genomics Basic Information, Manufacturing Base and Competitors
Table 120. BGI Genomics Major Business
Table 121. BGI Genomics Prenatal Second-Generation DNA Sequencing Product and Services
Table 122. BGI Genomics Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. BGI Genomics Recent Developments/Updates
Table 124. BGI Genomics Competitive Strengths & Weaknesses
Table 125. Berry Genomics Basic Information, Manufacturing Base and Competitors
Table 126. Berry Genomics Major Business
Table 127. Berry Genomics Prenatal Second-Generation DNA Sequencing Product and Services
Table 128. Berry Genomics Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Berry Genomics Recent Developments/Updates
Table 130. Berry Genomics Competitive Strengths & Weaknesses
Table 131. Annaroad Basic Information, Manufacturing Base and Competitors
Table 132. Annaroad Major Business
Table 133. Annaroad Prenatal Second-Generation DNA Sequencing Product and Services
Table 134. Annaroad Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Annaroad Recent Developments/Updates
Table 136. Annaroad Competitive Strengths & Weaknesses
Table 137. Weihansi Biomedical Technology Basic Information, Manufacturing Base and Competitors
Table 138. Weihansi Biomedical Technology Major Business
Table 139. Weihansi Biomedical Technology Prenatal Second-Generation DNA Sequencing Product and Services
Table 140. Weihansi Biomedical Technology Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Weihansi Biomedical Technology Recent Developments/Updates
Table 142. Weihansi Biomedical Technology Competitive Strengths & Weaknesses
Table 143. Global Key Players of Prenatal Second-Generation DNA Sequencing Upstream (Raw Materials)
Table 144. Global Prenatal Second-Generation DNA Sequencing Typical Customers
Table 1. World Prenatal Second-Generation DNA Sequencing Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Prenatal Second-Generation DNA Sequencing Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Prenatal Second-Generation DNA Sequencing Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Prenatal Second-Generation DNA Sequencing Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Prenatal Second-Generation DNA Sequencing Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Prenatal Second-Generation DNA Sequencing Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Prenatal Second-Generation DNA Sequencing Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Prenatal Second-Generation DNA Sequencing Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Prenatal Second-Generation DNA Sequencing Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Prenatal Second-Generation DNA Sequencing Players in 2025
Table 12. World Prenatal Second-Generation DNA Sequencing Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Prenatal Second-Generation DNA Sequencing Company Evaluation Quadrant
Table 14. Head Office of Key Prenatal Second-Generation DNA Sequencing Players
Table 15. Prenatal Second-Generation DNA Sequencing Market: Company Product Type Footprint
Table 16. Prenatal Second-Generation DNA Sequencing Market: Company Product Application Footprint
Table 17. Prenatal Second-Generation DNA Sequencing Mergers & Acquisitions Activity
Table 18. United States VS China Prenatal Second-Generation DNA Sequencing Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Prenatal Second-Generation DNA Sequencing Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Prenatal Second-Generation DNA Sequencing Companies, Headquarters (States, Country)
Table 21. United States Based Companies Prenatal Second-Generation DNA Sequencing Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Prenatal Second-Generation DNA Sequencing Revenue Market Share (2021-2026)
Table 23. China Based Prenatal Second-Generation DNA Sequencing Companies, Headquarters (Province, Country)
Table 24. China Based Companies Prenatal Second-Generation DNA Sequencing Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Prenatal Second-Generation DNA Sequencing Revenue Market Share (2021-2026)
Table 26. Rest of World Based Prenatal Second-Generation DNA Sequencing Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Prenatal Second-Generation DNA Sequencing Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Prenatal Second-Generation DNA Sequencing Revenue Market Share (2021-2026)
Table 29. World Prenatal Second-Generation DNA Sequencing Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Prenatal Second-Generation DNA Sequencing Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Prenatal Second-Generation DNA Sequencing Market Size by Type (2027-2032) & (USD Million)
Table 32. World Prenatal Second-Generation DNA Sequencing Market Size by Invasiveness, (USD Million), 2021 & 2025 & 2032
Table 33. World Prenatal Second-Generation DNA Sequencing Market Size Value by Invasiveness (2021-2026) & (USD Million)
Table 34. World Prenatal Second-Generation DNA Sequencing Market Size by Invasiveness (2027-2032) & (USD Million)
Table 35. World Prenatal Second-Generation DNA Sequencing Market Size by Service Model, (USD Million), 2021 & 2025 & 2032
Table 36. World Prenatal Second-Generation DNA Sequencing Market Size Value by Service Model (2021-2026) & (USD Million)
Table 37. World Prenatal Second-Generation DNA Sequencing Market Size by Service Model (2027-2032) & (USD Million)
Table 38. World Prenatal Second-Generation DNA Sequencing Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Prenatal Second-Generation DNA Sequencing Market Size by Application (2021-2026) & (USD Million)
Table 40. World Prenatal Second-Generation DNA Sequencing Market Size by Application (2027-2032) & (USD Million)
Table 41. Natera Basic Information, Manufacturing Base and Competitors
Table 42. Natera Major Business
Table 43. Natera Prenatal Second-Generation DNA Sequencing Product and Services
Table 44. Natera Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Natera Recent Developments/Updates
Table 46. Natera Competitive Strengths & Weaknesses
Table 47. Labcorp Basic Information, Manufacturing Base and Competitors
Table 48. Labcorp Major Business
Table 49. Labcorp Prenatal Second-Generation DNA Sequencing Product and Services
Table 50. Labcorp Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Labcorp Recent Developments/Updates
Table 52. Labcorp Competitive Strengths & Weaknesses
Table 53. Quest Diagnostics Basic Information, Manufacturing Base and Competitors
Table 54. Quest Diagnostics Major Business
Table 55. Quest Diagnostics Prenatal Second-Generation DNA Sequencing Product and Services
Table 56. Quest Diagnostics Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Quest Diagnostics Recent Developments/Updates
Table 58. Quest Diagnostics Competitive Strengths & Weaknesses
Table 59. MedGenome Basic Information, Manufacturing Base and Competitors
Table 60. MedGenome Major Business
Table 61. MedGenome Prenatal Second-Generation DNA Sequencing Product and Services
Table 62. MedGenome Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. MedGenome Recent Developments/Updates
Table 64. MedGenome Competitive Strengths & Weaknesses
Table 65. Mayo Clinic Laboratories Basic Information, Manufacturing Base and Competitors
Table 66. Mayo Clinic Laboratories Major Business
Table 67. Mayo Clinic Laboratories Prenatal Second-Generation DNA Sequencing Product and Services
Table 68. Mayo Clinic Laboratories Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Mayo Clinic Laboratories Recent Developments/Updates
Table 70. Mayo Clinic Laboratories Competitive Strengths & Weaknesses
Table 71. GeneDx Basic Information, Manufacturing Base and Competitors
Table 72. GeneDx Major Business
Table 73. GeneDx Prenatal Second-Generation DNA Sequencing Product and Services
Table 74. GeneDx Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. GeneDx Recent Developments/Updates
Table 76. GeneDx Competitive Strengths & Weaknesses
Table 77. PreventionGenetics Basic Information, Manufacturing Base and Competitors
Table 78. PreventionGenetics Major Business
Table 79. PreventionGenetics Prenatal Second-Generation DNA Sequencing Product and Services
Table 80. PreventionGenetics Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. PreventionGenetics Recent Developments/Updates
Table 82. PreventionGenetics Competitive Strengths & Weaknesses
Table 83. SYNLAB Basic Information, Manufacturing Base and Competitors
Table 84. SYNLAB Major Business
Table 85. SYNLAB Prenatal Second-Generation DNA Sequencing Product and Services
Table 86. SYNLAB Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. SYNLAB Recent Developments/Updates
Table 88. SYNLAB Competitive Strengths & Weaknesses
Table 89. Myriad Genetics Basic Information, Manufacturing Base and Competitors
Table 90. Myriad Genetics Major Business
Table 91. Myriad Genetics Prenatal Second-Generation DNA Sequencing Product and Services
Table 92. Myriad Genetics Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Myriad Genetics Recent Developments/Updates
Table 94. Myriad Genetics Competitive Strengths & Weaknesses
Table 95. GGA Basic Information, Manufacturing Base and Competitors
Table 96. GGA Major Business
Table 97. GGA Prenatal Second-Generation DNA Sequencing Product and Services
Table 98. GGA Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. GGA Recent Developments/Updates
Table 100. GGA Competitive Strengths & Weaknesses
Table 101. Fulgent Genetics Basic Information, Manufacturing Base and Competitors
Table 102. Fulgent Genetics Major Business
Table 103. Fulgent Genetics Prenatal Second-Generation DNA Sequencing Product and Services
Table 104. Fulgent Genetics Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Fulgent Genetics Recent Developments/Updates
Table 106. Fulgent Genetics Competitive Strengths & Weaknesses
Table 107. Rainbow Genomics Basic Information, Manufacturing Base and Competitors
Table 108. Rainbow Genomics Major Business
Table 109. Rainbow Genomics Prenatal Second-Generation DNA Sequencing Product and Services
Table 110. Rainbow Genomics Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Rainbow Genomics Recent Developments/Updates
Table 112. Rainbow Genomics Competitive Strengths & Weaknesses
Table 113. BillionToOne Basic Information, Manufacturing Base and Competitors
Table 114. BillionToOne Major Business
Table 115. BillionToOne Prenatal Second-Generation DNA Sequencing Product and Services
Table 116. BillionToOne Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. BillionToOne Recent Developments/Updates
Table 118. BillionToOne Competitive Strengths & Weaknesses
Table 119. BGI Genomics Basic Information, Manufacturing Base and Competitors
Table 120. BGI Genomics Major Business
Table 121. BGI Genomics Prenatal Second-Generation DNA Sequencing Product and Services
Table 122. BGI Genomics Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. BGI Genomics Recent Developments/Updates
Table 124. BGI Genomics Competitive Strengths & Weaknesses
Table 125. Berry Genomics Basic Information, Manufacturing Base and Competitors
Table 126. Berry Genomics Major Business
Table 127. Berry Genomics Prenatal Second-Generation DNA Sequencing Product and Services
Table 128. Berry Genomics Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Berry Genomics Recent Developments/Updates
Table 130. Berry Genomics Competitive Strengths & Weaknesses
Table 131. Annaroad Basic Information, Manufacturing Base and Competitors
Table 132. Annaroad Major Business
Table 133. Annaroad Prenatal Second-Generation DNA Sequencing Product and Services
Table 134. Annaroad Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Annaroad Recent Developments/Updates
Table 136. Annaroad Competitive Strengths & Weaknesses
Table 137. Weihansi Biomedical Technology Basic Information, Manufacturing Base and Competitors
Table 138. Weihansi Biomedical Technology Major Business
Table 139. Weihansi Biomedical Technology Prenatal Second-Generation DNA Sequencing Product and Services
Table 140. Weihansi Biomedical Technology Prenatal Second-Generation DNA Sequencing Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Weihansi Biomedical Technology Recent Developments/Updates
Table 142. Weihansi Biomedical Technology Competitive Strengths & Weaknesses
Table 143. Global Key Players of Prenatal Second-Generation DNA Sequencing Upstream (Raw Materials)
Table 144. Global Prenatal Second-Generation DNA Sequencing Typical Customers
LIST OF FIGURES
Figure 1. Prenatal Second-Generation DNA Sequencing Picture
Figure 2. World Prenatal Second-Generation DNA Sequencing Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Prenatal Second-Generation DNA Sequencing Total Revenue (2021-2032) & (USD Million)
Figure 4. World Prenatal Second-Generation DNA Sequencing Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Prenatal Second-Generation DNA Sequencing Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Prenatal Second-Generation DNA Sequencing Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Prenatal Second-Generation DNA Sequencing Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Prenatal Second-Generation DNA Sequencing Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Prenatal Second-Generation DNA Sequencing Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Prenatal Second-Generation DNA Sequencing Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Prenatal Second-Generation DNA Sequencing Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Prenatal Second-Generation DNA Sequencing Revenue (2021-2032) & (USD Million)
Figure 13. Prenatal Second-Generation DNA Sequencing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Prenatal Second-Generation DNA Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 16. World Prenatal Second-Generation DNA Sequencing Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Prenatal Second-Generation DNA Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 18. China Prenatal Second-Generation DNA Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Prenatal Second-Generation DNA Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Prenatal Second-Generation DNA Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Prenatal Second-Generation DNA Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Prenatal Second-Generation DNA Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 23. India Prenatal Second-Generation DNA Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Prenatal Second-Generation DNA Sequencing by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Prenatal Second-Generation DNA Sequencing Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Prenatal Second-Generation DNA Sequencing Markets in 2025
Figure 27. United States VS China: Prenatal Second-Generation DNA Sequencing Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Prenatal Second-Generation DNA Sequencing Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Prenatal Second-Generation DNA Sequencing Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Prenatal Second-Generation DNA Sequencing Market Size Market Share by Type in 2025
Figure 31. Targeted Panels
Figure 32. Exome Sequencing
Figure 33. Others
Figure 34. World Prenatal Second-Generation DNA Sequencing Market Size Market Share by Type (2021-2032)
Figure 35. World Prenatal Second-Generation DNA Sequencing Market Size by Invasiveness, (USD Million), 2021 & 2025 & 2032
Figure 36. World Prenatal Second-Generation DNA Sequencing Market Size Market Share by Invasiveness in 2025
Figure 37. Non-Invasive
Figure 38. Invasive
Figure 39. World Prenatal Second-Generation DNA Sequencing Market Size Market Share by Invasiveness (2021-2032)
Figure 40. World Prenatal Second-Generation DNA Sequencing Market Size by Service Model, (USD Million), 2021 & 2025 & 2032
Figure 41. World Prenatal Second-Generation DNA Sequencing Market Size Market Share by Service Model in 2025
Figure 42. Public Health Program
Figure 43. Consumer
Figure 44. Others
Figure 45. World Prenatal Second-Generation DNA Sequencing Market Size Market Share by Service Model (2021-2032)
Figure 46. World Prenatal Second-Generation DNA Sequencing Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 47. World Prenatal Second-Generation DNA Sequencing Market Size Market Share by Application in 2025
Figure 48. Public Hospitals
Figure 49. Private Hospitals
Figure 50. World Prenatal Second-Generation DNA Sequencing Market Size Market Share by Application (2021-2032)
Figure 51. Prenatal Second-Generation DNA Sequencing Industrial Chain
Figure 52. Methodology
Figure 53. Research Process and Data Source
Figure 1. Prenatal Second-Generation DNA Sequencing Picture
Figure 2. World Prenatal Second-Generation DNA Sequencing Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Prenatal Second-Generation DNA Sequencing Total Revenue (2021-2032) & (USD Million)
Figure 4. World Prenatal Second-Generation DNA Sequencing Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Prenatal Second-Generation DNA Sequencing Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Prenatal Second-Generation DNA Sequencing Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Prenatal Second-Generation DNA Sequencing Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Prenatal Second-Generation DNA Sequencing Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Prenatal Second-Generation DNA Sequencing Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Prenatal Second-Generation DNA Sequencing Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Prenatal Second-Generation DNA Sequencing Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Prenatal Second-Generation DNA Sequencing Revenue (2021-2032) & (USD Million)
Figure 13. Prenatal Second-Generation DNA Sequencing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Prenatal Second-Generation DNA Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 16. World Prenatal Second-Generation DNA Sequencing Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Prenatal Second-Generation DNA Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 18. China Prenatal Second-Generation DNA Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Prenatal Second-Generation DNA Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Prenatal Second-Generation DNA Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Prenatal Second-Generation DNA Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Prenatal Second-Generation DNA Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 23. India Prenatal Second-Generation DNA Sequencing Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Prenatal Second-Generation DNA Sequencing by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Prenatal Second-Generation DNA Sequencing Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Prenatal Second-Generation DNA Sequencing Markets in 2025
Figure 27. United States VS China: Prenatal Second-Generation DNA Sequencing Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Prenatal Second-Generation DNA Sequencing Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Prenatal Second-Generation DNA Sequencing Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Prenatal Second-Generation DNA Sequencing Market Size Market Share by Type in 2025
Figure 31. Targeted Panels
Figure 32. Exome Sequencing
Figure 33. Others
Figure 34. World Prenatal Second-Generation DNA Sequencing Market Size Market Share by Type (2021-2032)
Figure 35. World Prenatal Second-Generation DNA Sequencing Market Size by Invasiveness, (USD Million), 2021 & 2025 & 2032
Figure 36. World Prenatal Second-Generation DNA Sequencing Market Size Market Share by Invasiveness in 2025
Figure 37. Non-Invasive
Figure 38. Invasive
Figure 39. World Prenatal Second-Generation DNA Sequencing Market Size Market Share by Invasiveness (2021-2032)
Figure 40. World Prenatal Second-Generation DNA Sequencing Market Size by Service Model, (USD Million), 2021 & 2025 & 2032
Figure 41. World Prenatal Second-Generation DNA Sequencing Market Size Market Share by Service Model in 2025
Figure 42. Public Health Program
Figure 43. Consumer
Figure 44. Others
Figure 45. World Prenatal Second-Generation DNA Sequencing Market Size Market Share by Service Model (2021-2032)
Figure 46. World Prenatal Second-Generation DNA Sequencing Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 47. World Prenatal Second-Generation DNA Sequencing Market Size Market Share by Application in 2025
Figure 48. Public Hospitals
Figure 49. Private Hospitals
Figure 50. World Prenatal Second-Generation DNA Sequencing Market Size Market Share by Application (2021-2032)
Figure 51. Prenatal Second-Generation DNA Sequencing Industrial Chain
Figure 52. Methodology
Figure 53. Research Process and Data Source
